{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:06:35Z","timestamp":1785575195723,"version":"3.56.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1097\/ccm.0000000000003231","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T20:28:03Z","timestamp":1534451283000},"page":"1558-1559","source":"Crossref","is-referenced-by-count":10,"title":["On Benzodiazepines, Paradoxical Agitation, Hyperactive Delirium, and Chloride Homeostasis*"],"prefix":"10.1097","volume":"46","author":[{"given":"Jan N. M.","family":"Schieveld","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychology, Division of Child and Adolescent Psychiatry and Psychology, Maastricht University Medical Center+;, Department of Psychiatry and Neuropsychology, European Graduate School for Neuroscience (EURON);, South Limburg Mental Health Research & Teaching Network, Maastricht, The Netherlands; and Institution for Child & Youth psychiatry and psychology, Mutsaersstichting, Venlo, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline J. M. H.","family":"Strik","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Division of Child and Adolescent Psychiatry and Psychology, Maastricht University Medical Center+, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilgo","family":"Bruining","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230728","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects.","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000542-200601000-00005","article-title":"Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients.","volume":"104","author":"Pandharipande","year":"2006","journal-title":"Anesthesiology"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/CCM.0000000000003194","article-title":"Benzodiazepines and Development of Delirium in Critically Ill Children: Estimating the Causal Effect.","volume":"46","author":"Mody","year":"2018","journal-title":"Crit Care Med"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ncpneuro0883","article-title":"Roles of the cation-chloride cotransporters in neurological disease.","volume":"4","author":"Kahle","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.neuron.2016.02.030","article-title":"Chloride regulation: A dynamic equilibrium crucial for synaptic inhibition.","volume":"89","author":"Doyon","year":"2016","journal-title":"Neuron"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1542\/peds.2014-4133","article-title":"Paradoxical benzodiazepine response: A rationale for bumetanide in neurodevelopmental disorders?","volume":"136","author":"Bruining","year":"2015","journal-title":"Pediatrics"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/epi4.12032","article-title":"Behavioural disinhibition and antiepileptic treatment in childhood epilepsy: A retrospective cohort study.","volume":"2","author":"van Tuijl","year":"2017","journal-title":"Epilepsia Open"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tins.2017.07.001","article-title":"NKCC1 chloride importer antagonists attenuate many neurological and psychiatric disorders.","volume":"40","author":"Ben-Ari","year":"2017","journal-title":"Trends Neurosci"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"e1124","DOI":"10.1038\/tp.2017.101","article-title":"Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.","volume":"7","author":"Lemonnier","year":"2017","journal-title":"Transl Psychiatry"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fneur.2017.00469","article-title":"Bumetanide as a candidate treatment for behavioral problems in tuberous sclerosis complex.","volume":"8","author":"Vlaskamp","year":"2017","journal-title":"Front Neurol"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201809000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T08:02:40Z","timestamp":1690531360000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201809000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000003231","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}